NASDAQ:MASI - Masimo Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$122.00 +1.00 (+0.83 %)
(As of 09/21/2018 03:30 AM ET)
Previous Close$121.00
Today's Range$120.54 - $122.09
52-Week Range$80.69 - $124.00
Volume363,500 shs
Average Volume528,801 shs
Market Capitalization$6.37 billion
P/E Ratio49.73
Dividend YieldN/A
Beta1.02
Masimo logoMasimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000

Debt

Debt-to-Equity RatioN/A
Current Ratio5.05
Quick Ratio4.35

Price-To-Earnings

Trailing P/E Ratio49.73
Forward P/E Ratio42.07
P/E Growth2.88

Sales & Book Value

Annual Sales$798.11 million
Price / Sales7.92
Cash Flow$3.0146 per share
Price / Cash40.47
Book Value$13.68 per share
Price / Book8.92

Profitability

EPS (Most Recent Fiscal Year)$2.45
Net Income$131.61 million
Net Margins15.30%
Return on Equity21.49%
Return on Assets17.18%

Miscellaneous

Employees1,400
Outstanding Shares51,780,000
Market Cap$6.37 billion

Masimo (NASDAQ:MASI) Frequently Asked Questions

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) issued its quarterly earnings data on Wednesday, August, 1st. The medical equipment provider reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.71 by $0.02. The medical equipment provider earned $211.62 million during the quarter, compared to analysts' expectations of $207.85 million. Masimo had a return on equity of 21.49% and a net margin of 15.30%. The firm's quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.83 EPS. View Masimo's Earnings History.

When is Masimo's next earnings date?

Masimo is scheduled to release their next quarterly earnings announcement on Tuesday, October, 30th 2018. View Earnings Estimates for Masimo.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY18 earnings guidance on Wednesday, August, 1st. The company provided EPS guidance of $2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.89. The company issued revenue guidance of $850 million, compared to the consensus revenue estimate of $848.37 million.

What price target have analysts set for MASI?

5 analysts have issued 12 month target prices for Masimo's shares. Their predictions range from $94.00 to $112.00. On average, they expect Masimo's stock price to reach $100.75 in the next year. This suggests that the stock has a possible downside of 17.4%. View Analyst Price Targets for Masimo.

What is the consensus analysts' recommendation for Masimo?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Masimo.

Who are some of Masimo's key competitors?

Who are Masimo's key executives?

Masimo's management team includes the folowing people:
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 39)
  • Mr. Jon Coleman, Pres of Worldwide Sales, Professional Services & Medical Affairs (Age 54)
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 53)
  • Mr. Anand Sampath, Chief Operating Officer (Age 52)
  • Mr. David J. Van Ramshorst, Chief Accounting Officer & Sr. VP of Fin. (Age 57)

Has Masimo been receiving favorable news coverage?

Media stories about MASI stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Masimo earned a news impact score of 0.18 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Masimo.

Who are Masimo's major shareholders?

Masimo's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.04%), FMR LLC (3.52%), Schroder Investment Management Group (1.54%), Point72 Asset Management L.P. (1.43%), Bank of New York Mellon Corp (1.21%) and Bank of New York Mellon Corp (1.21%). Company insiders that own Masimo stock include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

Which major investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Voya Investment Management LLC, Northern Trust Corp, American Century Companies Inc., Acadian Asset Management LLC, Morgan Stanley and Canada Pension Plan Investment Board. Company insiders that have sold Masimo company stock in the last year include Bilal Muhsin, Joe E Kiani, Jon Coleman, Ramshorst David J Van, Sanford Fitch, Steven Barker and Yongsam Lee. View Insider Buying and Selling for Masimo.

Which major investors are buying Masimo stock?

MASI stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Schroder Investment Management Group, Caisse DE Depot ET Placement DU Quebec, Marshall Wace LLP, First Quadrant L P CA, Frontier Capital Management Co. LLC, Bank of Nova Scotia and Paloma Partners Management Co. View Insider Buying and Selling for Masimo.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $122.00.

How big of a company is Masimo?

Masimo has a market capitalization of $6.37 billion and generates $798.11 million in revenue each year. The medical equipment provider earns $131.61 million in net income (profit) each year or $2.45 on an earnings per share basis. Masimo employs 1,400 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]


MarketBeat Community Rating for Masimo (NASDAQ MASI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  296 (Vote Outperform)
Underperform Votes:  296 (Vote Underperform)
Total Votes:  592
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe MASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MASI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel